July 18th, 2011 by Elaine Schattner, M.D. in Opinion, Research
No Comments »
Yesterday’s post was not really about Avastin, but about medical journalism and how patients’ voices are handled by the media.
L. Husten, writing on a Forbes blog, cried that the press fawned, inappropriately, over patients’ words at the FDA hearing last week, and that led him to wonder why and if journalists should pay attention to what people with illness have to say, even if their words go against the prevailing medical wisdom.
There’s a fair amount of controversy on this. For sake of better discussion in the future, I think it best to break it up into 3 distinct but inter-related issues:
1. About health care journalism and patients’ voices:
A general problem I perceive (and part of why I started blogging) is how traditional medical journalists use patients’ stories to make a point. What some of my journalism professors tried to teach me, and most editors I’ve dealt with clearly want, is for the reporter to find a person with an illness, as a lead, and then tell about the relevant news, and provide some expert commentary – with at least one person speaking on each “side” of the issue, of course – and then end the story with some bit about the patient and the future.
I argue that this form of medical journalism Read more »
*This blog post was originally published at Medical Lessons*
December 27th, 2010 by John Mandrola, M.D. in Better Health Network, News, Opinion, Research
No Comments »
The end of the year marks a time for list-intensive posts. Recently Larry Husten from CardioExchange and CardioBrief asked for my opinion on the three most important cardiology-related news stories of 2010. Additionally, he wanted three predictions for 2011. Here goes:
Top Cardiology Stories Of 2010:
1. By far, the #1 heart story of 2010 was the release of the novel blood-thinning drug dabigatran (Pradaxa) for the prevention of stroke in atrial fibrillation. Until this October, the only way to reduce stroke risk in AF was warfarin, the active ingredient in rat poison. Assuming that there aren’t any post-market surprises, Pradaxa figures to be a true blockbuster. Doctors and patients have waited a long time to say goodbye to warfarin.
2. The Dr. Mark Midei stent story: Whether Dr. Midei is guilty or innocent of implanting hundreds of unnecessary stents isn’t really the big story. The real impact of this well-chronicled saga is the attention that it brings to the therapeutic misconceptions of coronary stenting. The problem with squishing and stenting is that although they improve the physics (of bloodflow), they do not change the biology of arterial disease — a hard concept to grasp when staring at a picture of a partial blockage. The vast press coverage of Dr. Midei’s alleged transgressions has served to educate many about heart disease, the nation’s #1 killer. Read more »
*This blog post was originally published at Dr John M*
October 30th, 2010 by GarySchwitzer in Better Health Network, Health Policy, News, Opinion, Quackery Exposed, Research
No Comments »
Kmart, Medtronic, and a bunch of specialty medical groups are sponsoring a campaign called “Find the AAAnswers” — the “AAA” standing for abdominal aortic aneurysm.
It’s clever marketing for Kmart’s pharmacy business, since the screenings are being offered throughout the Fall at more than 900 Kmart pharmacies. And it’s not bad business for the specialty medical groups, either, as Larry Husten wrote on his Cardiobrief blog:
…the expenses of the program and the coalition are entirely underwritten by Medtronic, which sells abdominal stent grafts used to repair AAAs, and the members of the coalition include organizations like the Peripheral Vascular Surgical Society, the Society for Vascular Surgery, and the Society for Vascular Ultrasound, whose members may derive a significant portion of their income from performing AAA repairs and screening.
Read more »
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*
August 21st, 2010 by John Mandrola, M.D. in Better Health Network, Health Tips, News, Opinion, Research
No Comments »
I saw a prescient story that linked antagonistic personality traits and cardiovascular risk. It was simply impossible to ignore. Low hanging fruit, no doubt.
The article highlights an NIH-sponsored study [published in the August 16th journal Hypertension] that looked at the effects of antagonistic traits — agreeableness, per se — on heart health. Yes, you read it right — agreeableness. To quantify agreeableness, the researchers used a personality questionnaire which included six traits: Trust, straightforwardness, altruism, compliance, modesty, and my favorite…tender-mindedness.
Your hypothesis is probably right: People who were distrustful, cynical, manipulative, self-centered, and quick to express anger fared worse. But please don’t dismiss this as just another mundane study proclaiming the risks of an angry personality. The specifics of the findings and their implications really hit hard. Read more »
*This blog post was originally published at Dr John M*
